A 32-year-old man developed gastroparesis after taking tirzepatide for weight loss, which isn't approved in India. Doctors ...
Phase 2 obesity co-administration study with MC4R agonist bremelanotide plus GLP-1/GIP dual agonist tirzepatide Database lock completed Topline data readout ...
A new study published JAMA Ophthalmology has brought attention to a series of vision problems observed in patients taking ...
Britain is in the grip of a gastric flu outbreak which has spread from hospitals in Scotland to the south coast, health chiefs said today. Levels of the virus, which has already affected 12 ...